Studies have shown that DPMAS combined with PE can supplement a certain amount of plasma to improve the coagulation function while actively supplementing albumin to reduce hypoproteinemia, effectively avoiding bleeding risks and hypoalbuminemia. The gene discussed is ALB; the disease is Hypoalbuminemia.